Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)
South Korea · Delayed Price · Currency is KRW 2,900.00
-70.00 (-2.36%)
At close: Oct 23, 2026
Vivozon Pharmaceutical Market Cap
Vivozon Pharmaceutical has a market cap or net worth of 174.48 billion as of October 23, 2026. It is the 23,170th most valuable company in the world and the 887th biggest in South Korea. Its market cap has decreased by 30.13% in one year.
Market Cap
174.48B
Enterprise Value
197.25B
Revenue
50.34B
Global Rank
Country Rank
#887 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 18, 2005, Vivozon Pharmaceutical's market cap has increased from 72.45B to 174.48B, an increase of 140.82%. That is a compound annual growth rate of 4.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 174.48B | -13.06% |
| Dec 30, 2025 | 200.68B | -40.93% |
| Dec 30, 2024 | 339.73B | 134.89% |
| Dec 28, 2023 | 144.64B | -2.99% |
| Dec 29, 2022 | 149.09B | -19.87% |
| Dec 30, 2021 | 186.05B | -37.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 279.23B |
| HEM Pharma | 215.19B |
| GC WellBeing | 202.73B |
| DAE HWA Pharmaceutical | 190.12B |
| NOVAREX | 167.21B |
| CellBion | 163.25B |
| Kyung Dong Pharmaceutical | 147.09B |
| HYUNDAI BIOLAND | 134.85B |